Unlike classical checkpoint molecules such as PD-1 which is associated with suppressed T-cell anti-tumor immunity and caused poor clinical outcomes in AML [28,29,30,31], TIM-3 molecule expression on various cell types showed multi-functional performance due to the complex intracellular signaling. Here, HAVCR2 is linked to acute myeloid leukemia.